- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06784271
Effect of Acute Phenylcapsaicin Intake on Trained Cross-Training Athletes (CROSSCAPS)
Effect of Acute Phenylcapsaicin Intake on Trained Cross-Training Athletes: a Randomized, Placebo-Controlled Crossover Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Capsaicin appears to enhance athletic performance by reducing perceived effort, increasing mechanical performance (e.g., total volume load), and decreasing muscle damage. Given the close relationship between the metabolic and physiological responses of cross-training and supplementation with Phenylcapsaicin (PC), it could be expected that consuming capsaicin during cross-training would have a favorable impact on perceived effort, recovery, and performance.
25 women and 24 men trained in CrossFit consumed either Phenylcapsaicin (PC) or a placebo during a CrossFit class, which consisted of a 16-minute weightlifting segment and a 15-minute WOD. Both the Rating of Perceived Exertion (RPE) and the Perceived Recovery Status scale (RPS) were administered at the beginning of the session and at the end of each segment of the CrossFit session. DOMS was assessed using a visual analog scale at 24 and 48 hours after the CrossFit session.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tenerife, Spain
- Universidad de la Laguna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18-35 years.
- Body mass index: 18.5-30 kg/m2.
- Ability to understand the instructions, objectives, and study protocol.
- Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
- Resident on the island of Tenerife.
Exclusion Criteria:
- History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
- Any chronic pathology in which the intake of nutritional supplements, especially pungent components, is not recommended.
- Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
- Use of medications that may affect the study results.
- Unstable body weight for 3 months prior to the start of the study (> 4 kg loss or gain in weight).
- Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
- On a special diet or prescribed for other reasons (e.g., celiac disease).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Phenylcapsaicin
2.5 mg of Phenylcapsaicin
|
2.5mg of Phenylcapsaicin
|
|
Placebo Comparator: Placebo
Preparation of colorants, sweeteners, aromas, and acidulants
|
Placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance
Time Frame: 60min
|
Performance measured through the countermovement jump
|
60min
|
|
Performance
Time Frame: 60min
|
Deep squat test at 70% of repetition maximum
|
60min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate
Time Frame: 60min
|
Heart rate will be measured with the Polar H10 heart rate monitor
|
60min
|
|
Subjective fatigue throughe the RPE scale
Time Frame: 60min
|
Rate of perceived exertion scale
|
60min
|
|
Recovery
Time Frame: 60min
|
Perceived Recovery Status Scale (RPS)
|
60min
|
|
Delayed-onset muscle soreness (DOMS)
Time Frame: 60min
|
Delayed-onset muscle soreness (DOMS) scale (0-10 arbitrary units)
|
60min
|
|
Capillar lactate levels
Time Frame: 60min
|
Capillar lactate levels
|
60min
|
|
Performance: Weight used in the crosstraining session
Time Frame: 60min
|
Weight used in the crosstraining session
|
60min
|
|
Performance: Time performed in the crosstraining session
Time Frame: 60min
|
Time performed in the crosstraining session
|
60min
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CROSSCAPS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Performance
-
Ankara UniversityBurdur Mehmet Akif Ersoy UniversityCompletedAnaerobic Performance Neuromuscular Performance Cognitive PerformanceTurkey (Türkiye)
-
Federal University of VicosaCompletedSprint Performance | Futsal | Jump Performance | Athletic Performance EnhancementColombia
-
Lindenwood UniversityCompletedExercise Performance | Exercise Performance of Fit Athletes | Cycling PerformanceUnited States
-
Gümüşhane UniversıtyCompletedInspiratory Muscle Training | Jump Performance | Shooting Performance | Precision Sport PerformanceTurkey (Türkiye)
-
Krzysztof MizeraCompletedCognitive Performance | Physical PerformancePoland
-
Shanghai University of SportRecruitingAthletic Performance | Physical PerformanceChina
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
University of GaziantepCompletedExercise Performance | Physical PerformanceTurkey (Türkiye)
-
Jacksonville State UniversityCompletedCognitive Function | Anaerobic Performance | Resistance Exercise Performance | Dietary Supplementation Athletic PerformanceUnited States
-
Federal University of VicosaCompletedAthletic Performance | Sprint Performance | YouthsColombia
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States